Company Filing History:
Years Active: 2010
Title: Jitendra Pandurang Suryavanshi: Innovator in Pharmaceutical Synthesis
Introduction
Jitendra Pandurang Suryavanshi is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of cost-effective processes for drug production. His innovative work has led to the creation of a patented process that enhances the efficiency and purity of pharmaceutical compounds.
Latest Patents
Suryavanshi holds a patent for an "Efficient process for production of carvedilol phosphate." This novel process focuses on the synthesis of phosphate salts of carvedilol, a medication used to treat high blood pressure and heart failure. The patent details a method for preparing crystalline phosphate salts using various phosphate-forming reagents, achieving high yields and purity. The solvents utilized in this process include acetonitrile, acetone, and tetrahydrofuran, with additional solvents for solvates being methanol, ethanol, and isopropyl alcohol.
Career Highlights
Suryavanshi is currently associated with Wanbury Limited, a company known for its commitment to pharmaceutical innovation. His work at Wanbury Limited has allowed him to apply his expertise in drug synthesis and contribute to the development of effective pharmaceutical solutions. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Suryavanshi has collaborated with talented professionals, including Shankar Sanganbhatla and Alam Sayyed Zahid. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Jitendra Pandurang Suryavanshi is a distinguished inventor whose work in pharmaceutical synthesis has made a significant impact. His patented process for the production of carvedilol phosphate exemplifies his commitment to advancing drug development. His contributions continue to influence the pharmaceutical industry positively.